20.05.2026, 20:55

Kazakhstan's PollenVax vaccine for wormwood allergy could reach market by 2030-2032

ASTANA. May 20 (Interfax-Kazakhstan) - Kazakh scientists are developing what they say is the world's first recombinant allergy vaccine, PollenVax, against wormwood pollen, with the vaccine potentially reaching the market by 2030-2032, the National Agriculture Scientific and Educational Center said.

To read the full news articles, Subscribe.